We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Acorda Therapeutics Inc | NASDAQ:ACOR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.661 | 0.565 | 0.5878 | 0 | 01:00:00 |
Delaware
|
|
13-3831168
|
(State or Other Jurisdiction of
Incorporation or Organization) |
|
(I.R.S. Employer Identification No.)
|
|
|
|
420 Saw Mill River Road
Ardsley, New York |
|
10502
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Large Accelerated Filer
☒
|
Accelerated
☐
|
Non-Accelerated Filer
☐
(Do not check if a smaller reporting company)
|
Smaller Reporting Company
☐
|
Title of Securities
to be Registered
|
Amount to
be Registered(1)
|
Proposed Maximum
Offering Price
Per Share (2)
|
Proposed Maximum
Aggregate
Offering Price (2)
|
Amount of
Registration Fee
|
Acorda Therapeutics, Inc. 2015 Omnibus Incentive Compensation Plan, Common Stock, $0.001 par value per share
|
$24.97
|
$52,437,000
|
$5,280.42
|
ACORDA THERAPEUTICS, INC.
|
||
By:
|
/s/ Ron Cohen, M.D.
|
|
Ron Cohen, M.D.
|
||
President and Chief Executive Officer
|
Name
|
Title
|
Date
|
|
/s/ Ron Cohen, M.D.
|
President, Chief Executive Officer and
|
August 4, 2016
|
|
Ron Cohen, M.D.
|
Director (Principal Executive Officer)
|
||
/s/ Michael Rogers
|
Chief Financial Officer (Principal Financial Officer
|
August 4, 2016
|
|
Michael Rogers
|
and Principal Accounting Officer)
|
Signatures
|
Title
|
Date
|
|
/s/ Barry Greene
|
Director
|
August 4, 2016
|
|
Barry Greene
|
|||
/s/ Peder K. Jensen, M.D.
|
Director
|
August 4, 2016
|
|
Peder K. Jensen, M.D.
|
|||
/s/ John P. Kelley
|
Director
|
August 4, 2016
|
|
John P. Kelley
|
|||
/s/ Sandra Panem, Ph.D.
|
Director
|
August 4, 2016
|
|
Sandra Panem, Ph.D.
|
|||
/s/ Lorin J. Randall
|
Director
|
August 4, 2016
|
|
Lorin J. Randall
|
|||
/s/ Steven M. Rauscher, M.B.A.
|
Director
|
August 4, 2016
|
|
Steven M. Rauscher, M.B.A.
|
|||
/s/ Ian F. Smith
|
Director
|
August 4, 2016
|
|
Ian F. Smith
|
Number
|
|
Description
|
|
|
|
4.1
|
Acorda Therapeutics, Inc. 2015 Omnibus Incentive Compensation Plan as amended on June 8, 2016. Incorporated by reference to Appendix A to the Registrant's 2015 Proxy Statement filed as Schedule 14A (File Number 000-50513) on April 30, 2015.
|
|
5.1
|
|
Opinion of Covington & Burling LLP, counsel to the Registrant
|
|
|
|
23.1
|
|
Consent of Covington & Burling LLP (included in Exhibit 5.1)
|
|
|
|
23.2
|
|
Consent of Ernst & Young LLP
|
24.1
|
Power of Attorney of all directors of the board of directors of the Registrant (included on the signature pages of this registration statement)
|
1 Year Acorda Therapeutics Chart |
1 Month Acorda Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions